Dynamic RegeTissue

BiotechnologyAngelShanghai, China

Latest round

Angel

Last raised

Jan 2026

Total raised

Undisclosed

Investors

1

About Dynamic RegeTissue

, trading as Dynamic RegeTissue focuses on iPSC-based regenerative tissue products (“ready-to-use” micro-organs). The company targets the “stem cells + engineered scaffolds” intersection, developing functional micro-organ products on 3D biodegradable oriented micro-fiber scaffolds for major diseases.1 mm thickness, targeting severe/terminal heart failure with potential minimally invasive thoracoscopic delivery) and iPSC-derived MSC skin tissue sheets (for burns/chronic non-healing wounds such as diabetic foot ulcers, promoting angiogenesis and tissue reconstruction); it also out-licenses/partners its platform capabilities (3D scaffolds, micro-tissue construction, cardiac toxicity models) for external collaborative research and services. Revenue comes from out-licensing/co-development, platform services (evaluation models, scaffold technologies), and commercialization of tissue-sheet products for cardiac repair and advanced wound care.

Who invested in Dynamic RegeTissue

1 investor across 1 round

See all investors in Dynamic RegeTissue

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Jan 4, 2026

    Amount

    Undisclosed

    Investors

    Locked

Questions about Dynamic RegeTissue

Who invested in Dynamic RegeTissue?

Dynamic RegeTissue has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Dynamic RegeTissue raised?

Dynamic RegeTissue has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Dynamic RegeTissue last raise money?

Dynamic RegeTissue's most recent round on record is a Angel, in Jan 2026.

What does Dynamic RegeTissue do?

, trading as Dynamic RegeTissue focuses on iPSC-based regenerative tissue products (“ready-to-use” micro-organs).

Where is Dynamic RegeTissue headquartered?

Dynamic RegeTissue is headquartered in Shanghai, China.

Which VCs invest in companies like Dynamic RegeTissue?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Dynamic RegeTissue's stage. Their profiles are linked below.

Raising like Dynamic RegeTissue? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.